All news

Philips books EUR 288 million to settle US case over sleep apnoea devices

DutchNews · · AI-summarised by FinFlash

Philips reached an agreement in principle with the US Justice Department worth EUR 288 million over defective Respironics sleep apnoea devices, disclosing the figure in its quarterly results. The recall covered 5.5 million machines and 17 million masks. Third-quarter sales rose 3% to EUR 4.4 billion, while profit fell to EUR 28 million from EUR 187 million, partly because of the settlement. Chief executive Roy Jakobs called it a very important step.

So What?

Removing a long-running legal overhang is a positive for Philips' risk profile, though the charge dented quarterly profit. Watch final settlement terms and order momentum.

Read original source

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.